RMB. Another note ...AMLX recently did a capital raise ...and the stock went UP. !!!! ( usually the opposite happens )
September 10 2025 - 12:06AM
Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (“Amylyx” or the “Company”) today announced the pricing of an underwritten public offering of 17,500,000 shares of its common stock at a public offering price of $10.00 per share
Goldman Sachs analyst Corinne Johnson maintains Amylyx Pharmaceuticals ( AMLX ) with a Buy and raises the price target from $10 to $20.
Market Data 
Markets 
AI
